Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Registered Secondary Public Offering of American Depositary Shares by Certain Pre-IPO Shareholders of I-Mab Has Priced 2021-02-09 21:00
Proposed Registered Secondary Public Offering of American Depositary Shares by Certain Pre-IPO Shareholders of I-Mab 2021-02-06 06:27
I-Mab Announces Multiple Clinical Advancements of Its Differentiated CD73 Antibody Uliledlimab in China and the U.S. 2021-02-05 21:00
I-Mab Announces First Patient Dosed in Phase 2 Clinical Trial of TJ107 in Glioblastoma Multiforme in China 2021-02-04 21:00
Covid-19 Drug Duo Achievements: GoldenBiotech's New Drug Antroquinonol (HOCENA) Trial Receives Positive Response from DMC Review and Licenses for 4 Countries 2021-02-04 18:41
Eucure Biopharma Announces Encouraging Antitumor Activity of Its anti-CD40 Antibody in PD-1 Refractory Ocular Melanoma when Combined with Junshi Biosciences' Toripalimab 2021-02-03 23:45
More Patients Set to Benefit as Kanghong Pharmaceutical Targets New Indications with Conbercept 2021-02-03 22:00
Longevity Acquisition Corporation Announces 4D pharma Update on Oncology Program 2021-02-03 22:00
Nippon Express (Thailand) Obtains GDP Certification for Domestic Transport Services 2021-02-02 14:00
Kintor's GT20029 IND for PROTAC AR Degrader Was Accepted by NMPA 2021-02-02 12:11
DW Healthcare Partners Invests in Parnell 2021-02-02 08:23
Clover Biopharmaceuticals Announces Publication of Phase 1 Clinical Trial Data for its Adjuvanted COVID-19 Vaccine Candidates in The Lancet 2021-02-01 14:00
DWHP Announces Expiration And Final Results Of Its Cash Tender Offer For All Outstanding Ordinary Shares Of Parnell Pharmaceuticals Holdings Ltd. 2021-01-30 07:38
Nippon Express Bangladesh Obtains GDP Certification for Air Cargo Import/Export Services 2021-01-29 15:00
Immunoforge's 'PF1801' Is Designated as Orphan Drug by FDA 2021-01-28 22:00
Samsung Biologics, National OncoVenture, and Eutilex Obtain IND Approval from FDA 2021-01-27 08:26
I-Mab and MorphoSys Announce First Patient Dosed in U.S. Phase 1 Study of TJ210/MOR210 in Patients with Advanced Cancer 2021-01-26 05:05
BioNTech and Fosun Pharma Receive Authorization for Emergency Use in Hong Kong for COVID-19 Vaccine 2021-01-26 01:18
China Biologic Announces Extraordinary General Meeting of Shareholders 2021-01-25 21:44
Senhwa Announces the First Patient Enrolled in an Investigator Initiated Trial Of Silmitasertib as a Treatment for Patients with Severe COVID-19 2021-01-22 12:00
1 115 116 117 118 119 170